SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patientsCase Report Published on 2021-04-212023-06-16 Journal: Journal of Neurology [Category] MERS, SARS, [키워드] COVID-19 FDG-PET/CT Neuroimaging Neurological complications Parkinson’s disease Parkinsonism [DOI] 10.1007/s00415-021-10560-3 PMC 바로가기 [Article Type] Case Report
Effects of the COVID-19 Pandemic on Parkinson’s Disease: a Single-Centered Qualitative StudyOriginal Article Published on 2021-04-122022-10-31 Journal: The Canadian Journal of Neurological Sciences. Le [Category] COVID-19, MERS, [키워드] activity affected analyzed Attitude Calgary Care clinical clinical care coded COVID-19 COVID-19 pandemic Daily diagnosed Effect Health Impact impacted initial interview limitation Movement disorder neurological observé pandemic Parkinson’s disease Parkinson’s disease participant Patient provide public health measure Qualitative quality of care Quality of life reported researcher risk social interaction Symptom transcribed transcript unique Virtual care were recorded worsening [DOI] 10.1017/cjn.2021.70 PMC 바로가기 [Article Type] Original Article
Impact of COVID-19 Pandemic on Patients With Neurodegenerative DiseasesNeuroscience Published on 2021-04-082022-10-31 Journal: Frontiers in Aging Neuroscience [Category] COVID-19, [키워드] Affect Alzheimer’s disease Alzheimer’s disease (AD) Amyotrophic lateral sclerosis Care Coronavirus disease 2019 COVID-19 COVID-19 pandemic Creutzfeldt-Jakob disease disease Diseases elderly Fatality rate global health security Impact incurable myelin sheath neurodegenerative Neurological disorder Parkinson’s disease Parkinson’s disease Pathogenesis Population potential mechanism produced SARS-COV-2 infection Severe Acute Respiratory Syndrome-associated Coronavirus 2 the patient underlying diseases [DOI] 10.3389/fnagi.2021.664965 PMC 바로가기 [Article Type] Neuroscience
Deep Brain Stimulation for Parkinson’s Disease During the COVID-19 Pandemic: Patient PerspectiveNeuroscience Published on 2021-04-012022-10-31 Journal: PeerJ [Category] COVID-19, [키워드] activity Administered Brain Care changed consecutive patient coronavirus COVID-19 COVID-19 pandemic daily living deep deep brain stimulation Elective surgery Government Health health care systems hospital hospitals impacted majority MOST outbreak pandemic Parkinson’s disease Parkinson’s disease Patient Person-centered care Prevent preventive measure Public public health questionnaire Region Regulation Result routine Ruijin seeking Shanghai Stimulation Symptom the patient virus spread [DOI] 10.3389/fnhum.2021.628105 PMC 바로가기 [Article Type] Neuroscience
Parkinson’s Disease Causative Mutation in Vps35 Disturbs Tetherin Trafficking to Cell Surfaces and Facilitates Virus SpreadArticle Published on 2021-03-282022-10-31 Journal: Cells [Category] COVID-19, SARS, [키워드] aspartate carriers Causative Cell characterized disorder ectopic expression Endosomes etiology expressing facilitate Frequency herpes simplex herpes simplex virus host cell HSV-1 implicated Infection Inhibitory effects investigated less misfolded protein mutant Mutation mutations neurodegenerative Neuroinflammation Neuron ortholog overexpressing Parkinson’s disease Parkinson’s disease Parkinsonism precipitated proliferation Protein reduced significantly Spread substantia surface tetherin vacuolar vesicles virus virus spread Vps35 wildtype [DOI] 10.3390/cells10040746 PMC 바로가기 [Article Type] Article
Alzheimer’s and Parkinson’s Diseases Predict Different COVID-19 Outcomes: A UK Biobank StudyArticle Published on 2021-01-262022-10-31 Journal: Geriatrics [Category] COVID-19, [키워드] acute respiratory syndrome addition advanced age Affect affected age Alzheimer’s disease Alzheimer’s disease analysed China coronavirus coronavirus disease COVID-19 COVID-19 susceptibility death described determinant diabete Diagnosis died disease global pandemic Health higher risk highest humans hypertension individual individuals infecting Medical conditions Mortality neurodegeneration neurodegenerative neurodegenerative disorders Parkinson’s disease Parkinson’s disease Patient predict Prevalence recent reported risk of COVID-19 SARS-CoV-2 SARS-COV-2 infection scrutiny Spread tested those with comorbidities UK biobank United Kingdom Wuhan [DOI] 10.3390/geriatrics6010010 PMC 바로가기 [Article Type] Article
Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from WuhanObservational Study Published on 2021-01-032022-10-04 Journal: Journal of neural transmission (Vienna, Austria : [Category] MERS, 임상, [키워드] Admission affecting age analyzed clinical Clinical characteristics clinical outcomes collected Complication complications COVID-19 COVID-19 infection Critical death disorder disturbance of consciousness incidence increased risk late stage neutrophil no significant difference Non-survivors Older age outcome outcomes overall mortality Parkinson’s disease Parkinson’s disease Patient Prognosis progressed proportion risk factor SARS-CoV-2 severe COVID-19 Severe COVID-19 Infection severe COVID-19 patient supplementary material susceptible Union Hospital White blood cell Wuhan [DOI] 10.1007/s00702-020-02283-y PMC 바로가기 [Article Type] Observational Study
Challenges in treating people with Parkinson’s disease during the COVID-19 pandemicLetter to the Editor Published on 2020-11-252022-10-27 Journal: Bulletin of Faculty of Physical Therapy [Category] COVID-19, [키워드] challenge COVID-19 COVID-19 pandemic Parkinson’s disease Parkinson’s disease telehealth telerehabilitation [DOI] 10.1186/s43161-020-00017-5 PMC 바로가기 [Article Type] Letter to the Editor
Emerging Neurological and Psychobiological Aspects of COVID-19 InfectionReview Published on 2020-11-122022-10-28 Journal: Brain Sciences [Category] COVID-19, [키워드] acute phase Affect aspect Asymptomatic blood vessels caused Central nervous system China clinical conditions clinical manifestation CNS COVID-19 COVID-19 infection COVID-19 pandemic Critical Cytokines death Evidence Infection kidneys life-threatening liver nervous system neuro-COVID neurological occur organ Parkinson’s disease pathophysiology people with COVID-19 Peripheral nervous system pharmacological Psychological psychological symptom reported Research Respiratory system SARS-CoV-2 SARS-CoV-2 virus Symptom [DOI] 10.3390/brainsci10110852 PMC 바로가기 [Article Type] Review
COVID-19 and Parkinson’s Disease: Shared Inflammatory Pathways Under Oxidative Stress †Article Published on 2020-10-312022-10-28 Journal: Brain Sciences [Category] COVID-19, [키워드] 6OHDA Activation acute respiratory syndrome affected alignment Apoptosis basic Bioinformatics analysis Brain caspase caused cell line Chronic disorder complications contribute coronavirus correlated COVID-19 death ENhance Evidence exacerbate Health human cell identify immortalized Increasing indicated individual Infection inflammatory pathway inhibitors knowledge laboratory data literature review Neuron NFκB nuclear factor kappa B (NFκB) oxidative stress pandemic Parkinson’s disease Parkinson’s disease pathway Patient progression proteome reduced resulting SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 protein selective similarity specific inhibitor Therapeutic approach Toxicity Treatment triggered [DOI] 10.3390/brainsci10110807 PMC 바로가기 [Article Type] Article